T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.57B |
| 2 |
Elevance Health
ELV
|
+$1.16B |
| 3 |
BXLT
BAXALTA INC COM STK (DE)
BXLT
|
+$1.01B |
| 4 |
Royal Caribbean
RCL
|
+$860M |
| 5 |
AET
Aetna Inc
AET
|
+$790M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Baidu
BIDU
|
+$1.76B |
| 2 |
Biogen
BIIB
|
+$1.47B |
| 3 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$1.26B |
| 4 |
McKesson
MCK
|
+$1.2B |
| 5 |
Sherwin-Williams
SHW
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 21.75% |
| 2 | Consumer Discretionary | 14.84% |
| 3 | Financials | 13.9% |
| 4 | Technology | 11.11% |
| 5 | Industrials | 9.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Citizens Financial Group
CFG
$31.2B
| $2.23M | ﹤0.01% |
93,500
+49,600
| +113% | +$1.27M |
|
1527
Liberty Media Series A
FWONA
$23.7B
| $2.2M | ﹤0.01% |
91,423
-2,050
| -2% | -$51K |
|
1528
Voya Financial
VOYA
$9.16B
| $2.19M | ﹤0.01% |
56,600
+9,100
| +19% | +$400K |
|
|
WR
1529
DELISTED
Westar Energy Inc
WR
| $2.19M | ﹤0.01% |
56,850
+3,000
| +6% | +$111K |
|
1530
AGNC Investment
AGNC
$13B
| $2.18M | ﹤0.01% |
116,755
-3,015
| -3% | -$57.9K |
|
|
GLOP
1531
DELISTED
GASLOG PARTNERS LP
GLOP
| $2.17M | ﹤0.01% |
134,570
+1,040
| +0.8% | +$19.7K |
|
1532
W.P. Carey
WPC
$16.3B
| $2.15M | ﹤0.01% |
37,930
| – | – |
|
1533
Bio-Techne
TECH
$11.2B
| $2.15M | ﹤0.01% |
92,892
+120
| +0.1% | +$3.01K |
|
1534
Universal Technical Institute
UTI
$1.42B
| $2.11M | ﹤0.01% |
602,200
+75,000
| +14% | +$420K |
|
|
ESPR
1535
DELISTED
Esperion Therapeutics
ESPR
| $2.11M | ﹤0.01% |
89,272
| – | – |
|
1536
NVR
NVR
$17B
| $2.09M | ﹤0.01% |
1,373
-100
| -7% | -$149K |
|
|
Y
1537
DELISTED
Alleghany Corp
Y
| $2.07M | ﹤0.01% |
4,426
| – | – |
|
1538
BWX Technologies
BWXT
$15.6B
| $2.02M | ﹤0.01% |
76,672
-637,618
| -89% | -$16.3M |
|
|
SCTY
1539
DELISTED
SolarCity Corporation
SCTY
| $2.02M | ﹤0.01% |
47,216
+36,816
| +354% | +$1.85M |
|
1540
Canadian National Railway
CNI
$77.2B
| $2M | ﹤0.01% |
35,420
+1,900
| +6% | +$111K |
|
|
FLG
1541
Flagstar Bank National Association
FLG
$5.92B
| $2M | ﹤0.01% |
36,995
| – | – |
|
1542
Novartis
NVS
$288B
| $2M | ﹤0.01% |
24,282
-378,882
| -94% | -$33.7M |
|
1543
AXIS Capital
AXS
$7.3B
| $2M | ﹤0.01% |
37,200
| – | – |
|
1544
Reinsurance Group of America
RGA
$16.4B
| $2M | ﹤0.01% |
22,020
| – | – |
|
1545
Avnet
AVT
$7.87B
| $1.98M | ﹤0.01% |
46,398
+2,100
| +5% | +$87.4K |
|
|
WLL
1546
DELISTED
Whiting Petroleum Corporation
WLL
| $1.98M | ﹤0.01% |
431
-4,411
| -91% | -$27.3M |
|
1547
UGI
UGI
$7.56B
| $1.97M | ﹤0.01% |
56,440
-3,700
| -6% | -$129K |
|
|
VER
1548
DELISTED
VEREIT, Inc.
VER
| $1.96M | ﹤0.01% |
50,887
| – | – |
|
1549
ResMed
RMD
$32.9B
| $1.96M | ﹤0.01% |
38,519
+205
| +0.5% | +$11K |
|
1550
Manitowoc
MTW
$753M
| $1.94M | ﹤0.01% |
142,863
-1,893,402
| -93% | -$29.2M |
|
Similar funds
T. Rowe Price Associates's Q3 2015 Portfolio in Review
As of Q3 2015, T. Rowe Price Associates held 2,618 positions worth $449B, down 7.6% from $486B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
T. Rowe Price Associates's Q3 2015 filing shows 86 new, 1,108 increased, 800 reduced and 108 closed positions. Its largest new stake was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M. The largest sale was Baidu, an estimated $1.76B.
By sector, the portfolio is most concentrated in Healthcare at 22% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- T. Rowe Price Associates's largest Q3 2015 buy was BAXALTA INC COM STK (DE): 29,330,491 shares worth $924M.
- T. Rowe Price Associates added most to Microsoft in Q3 2015, an estimated $1.57B increase.
- T. Rowe Price Associates's biggest Q3 2015 reduction was Baidu, cutting an estimated $1.76B.
- T. Rowe Price Associates fully exited HOSPIRA INC in Q3 2015, selling an estimated $988M.
- T. Rowe Price Associates's ten largest holdings make up 16% of its $449B portfolio in Q3 2015.
- T. Rowe Price Associates opened 86 new positions and closed 108 in Q3 2015.
- T. Rowe Price Associates's portfolio value fell 7.6% quarter-over-quarter to $449B.
Based on T. Rowe Price Associates's 13F filing for Q3 2015, filed 13 Nov 2015.